Banyan Pacific Capital

Since 2015, Banyan Pacific Capital (BPC) has been investing in technology and life science companies both in China and US. BPC invests in top-tier funds as well as startups directly with a cumulative investment amount of $ 1.3 billion. The investment stage of BPC includes seed to Pre-IPO. The focus areas are deep tech, biotech and health, and consumer. BPC has invested up to 10 venture funds in the US and 15 startups. One exits, and three are in the 2022 IPO pipeline. We’ve established strategic partnerships with a number of outstanding venture capitals to build an extensive investment ecosystem. We’ve established strategic partnerships with a number of outstanding venture capitals to build an extensive investment ecosystem. BPC has offices in Silicon Valley, Hong Kong, Beijing, Shanghai, and Shenzhen.